FDA’s Woodcock Holds Meeting on Regulatory Pathways for Hemp and CBD
On November 1, 2022, the Principal Deputy Commissioner of the U.S. Food and Drug Administration (FDA) Janet Woodcock had a virtual meeting on “Regulatory Pathways for Hemp Products, including Cannabidiol (CBD)” with representatives of the U.S. Health and Human Services Office of the Secretary and the Executive Office of the President. This meeting was announced […]
FDA’s Woodcock Holds Meeting on Regulatory Pathways for Hemp and CBD Read More »

































